ZETAONC Trademark

Trademark Overview


On Thursday, November 11, 2021, a trademark application was filed for ZETAONC with the United States Patent and Trademark Office. The USPTO has given the ZETAONC trademark a serial number of 97119621. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, August 21, 2024. This trademark is owned by Zetagen Therapeutics, Inc.. The ZETAONC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of metastatic tumors and lesions; Pharmaceuticals, namely, for destroying, inhibiting or preventing the spread of uncontrolled growth of abnormal tissues, namely, metastatic tumors and lesions
zetaonc

General Information


Serial Number97119621
Word MarkZETAONC
Filing DateThursday, November 11, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of metastatic tumors and lesions; Pharmaceuticals, namely, for destroying, inhibiting or preventing the spread of uncontrolled growth of abnormal tissues, namely, metastatic tumors and lesions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 18, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZetagen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210

Party NameZetagen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210

Trademark Events


Event DateEvent Description
Thursday, June 30, 2022ASSIGNED TO EXAMINER
Thursday, June 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 15, 2021NEW APPLICATION ENTERED
Thursday, November 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, March 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 14, 2023SOU EXTENSION 2 FILED
Thursday, September 14, 2023SOU EXTENSION 2 GRANTED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 9, 2023SOU EXTENSION 1 FILED
Thursday, March 9, 2023SOU EXTENSION 1 GRANTED
Thursday, September 14, 2023SOU TEAS EXTENSION RECEIVED
Saturday, September 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Tuesday, February 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 20, 2024SOU EXTENSION 3 FILED
Tuesday, February 20, 2024SOU EXTENSION 3 GRANTED
Wednesday, February 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU EXTENSION 4 GRANTED
Wednesday, August 21, 2024SOU EXTENSION 4 FILED